Albert David (NSE:ALBERTDAVD) 5-Year Yield-on-Cost %: 0.58 (As of Aug. 25, 2026) — 57% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ALBERTDAVD Albert David Ltd NSE:ALBERTDAVD
72 GF Score
Price ₹888.70
GF Value ₹905.22
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Albert David 5-Year Yield-on-Cost %?

Albert David NSE:ALBERTDAVD +2.84% 72 5-Year Yield-on-Cost % is 0.58 as of Aug. 25, 2026, which is 57% below its 10-year median of 1.35. GuruFocus rates NSE:ALBERTDAVD with a GF Score™ of 72/100 and a GF Value™ of ₹905.22 (Fairly Valued). The stock has 7 warning signs investors should review. Among 507 Drug Manufacturers companies, Albert David ranks worse than 80.08% on this metric.

Albert David's yield on cost for the quarter that ended in Jun. 2026 was 0.58.


The historical rank and industry rank for Albert David's 5-Year Yield-on-Cost % or its related term are showing as below:

NSE:ALBERTDAVD' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.55   Med: 1.35   Max: 4.07
Current: 0.58


During the past 13 years, Albert David's highest Yield on Cost was 4.07. The lowest was 0.55. And the median was 1.35.


NSE:ALBERTDAVD's 5-Year Yield-on-Cost % is ranked worse than
80.08% of 507 companies
in the Drug Manufacturers industry
Industry Median: 2.36 vs NSE:ALBERTDAVD: 0.58

Albert David  (NSE:ALBERTDAVD) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Albert David 5-Year Yield-on-Cost % Related Terms


NSE:ALBERTDAVD vs ZTS: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Albert David's 5-Year Yield-on-Cost % falls into.


NSE:ALBERTDAVD
72GF Score
Albert David Ltd NSE:ALBERTDAVD
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Albert David 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Albert David is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.58 mean?
Albert David (NSE:ALBERTDAVD) has a 5-Year Yield-on-Cost % of 0.58 as of Aug. 25, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Albert David and its competitors. This is 57% below median its historical median of 1.35. Over the past decade, Albert David's 5-Year Yield-on-Cost % has ranged from 0.55 to 4.07. According to the industry distribution chart, Albert David ranks #406 out of 507 companies in the Drug Manufacturers industry, placing it in the top 80.1%.
Is Albert David's 5-Year Yield-on-Cost % too high?
Albert David's current 5-Year Yield-on-Cost % of 0.58 is 57% below median its 10-year median of 1.35. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 4.07. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.36. Albert David's value of 0.58 is 75.4% below this industry median. Based on the distribution chart, Albert David ranks #406 out of 507 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Albert David has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Albert David's 5-Year Yield-on-Cost % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Albert David ranks #406 out of 507 companies for 5-Year Yield-on-Cost %. This places Albert David in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.36. Albert David's value of 0.58 is 75.4% below this benchmark. Historically, Albert David's own 5-Year Yield-on-Cost % has ranged from 0.55 to 4.07 over the past decade. While the company's 10-year median is 1.35 vs. the industry median of 2.36, Albert David has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.36, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Albert David's current 5-Year Yield-on-Cost % of 0.58 is 75.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Albert David and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Albert David's current 5-Year Yield-on-Cost % is 0.58, which is 57% below median its own 10-year median of 1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albert David stock overvalued right now?
Based on GuruFocus' analysis, Albert David (NSE:ALBERTDAVD) is currently considered Fairly Valued. The stock's GF Value™ is ₹905.22, compared to a current price of ₹888.70 — trading 1.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.58, which is 57% below median its 10-year median of 1.35 and 75.4% below the Drug Manufacturers industry median of 2.36. Albert David's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Albert David (NSE:ALBERTDAVD), the current 5-Year Yield-on-Cost % is 0.58 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Albert David (NSE:ALBERTDAVD) Overvalued in 2026?

Based on GuruFocus' analysis, Albert David stock appears to be undervalued. The current stock price of ₹888.70 is trading 1.8% below its estimated GF Value™ of ₹905.22. GuruFocus considers Albert David to be Fairly Valued.

Key valuation signals for NSE:ALBERTDAVD:

  • 5-Year Yield-on-Cost %: 0.58 (57% below median its 10-year median of 1.35)
  • GF Value™: ₹905.22 vs. price of ₹888.70 (1.8% below fair value)
  • GF Score™: 72/100 with 7 warning signs
  • Industry Position: 75.4% below the Drug Manufacturers median (#406 of 507)

No single metric tells the full story. See the NSE:ALBERTDAVD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Albert David Business Description

Other Exchanges 524075:India
Address 8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, Southeast Asia, and a few African countries. The Company is only engaged in the manufacturing of pharmaceutical products, ipso facto, one reportable segment.
72GF Score

Get the complete analysis for NSE:ALBERTDAVD

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹888.70
Price
₹905.22
GF Value